相关实验视频

Updated: Sep 11, 2025

LAD-Ligation: A Murine Model of Myocardial Infarction

LAD-Ligation: A Murine Model of Myocardial Infarction

Published on: October 14, 2009

特定于心肌细胞的LARP6过度表达可以防止血管激素II诱导的心肌功能障碍和间歇性纤维化

Jacob Jeffrey Russell^1,2, Tadashi Yoshida³, Lixin Ma^1,4

¹Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA.

American journal of physiology. Heart and circulatory physiology

|August 18, 2025

概括

令人惊的是,心脏细胞中的La ribonucleoprotein 6 (LARP6) 过度表达可以防止由高血压引起的心脏功能障碍和纤维化. 这一发现表明LARP6可能是高血压心脏病的治疗点.

科学领域:

心脏病学心脏病学
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

核蛋白6 (LARP6) 是已知的非心脏组织中的亲纤维蛋白.
它在心肌细胞和心脏重塑中的作用目前尚不清楚.
研究心脏中的LARP6对于理解心脏病至关重要.

研究的目的:

研究心肌细胞特异性LARP6在心脏功能和重塑中的作用.
为了确定LARP6过度表达是否会加剧或防止高血压心脏应激.
探索LARP6在高血压心脏病中的治疗潜力.

主要方法:

产生了一个心肌细胞特异性LARP6过度表达的转基因小鼠模型 (LARP6-Tg).
评估LARP6-Tg小鼠与野生型 (WT) littermates的心脏功能和形态.
诱导高血压和心脏重塑使用血管素II (Ang II) 输注在两种基因型.

主要成果:

构成性LARP6过度表达没有对心脏功能产生基线影响,但诱导了轻微的间歇性纤维化.
在WT和LARP6-Tg小鼠中, ангиотензинII输液诱导高血压和心脏缩.
意想不到的是,LARP6-Tg小鼠受到Ang II诱导的心脏功能障碍,间歇性纤维化和心肌细胞死亡的保护.

结论:

特定于心肌细胞的LARP6过度表达在没有压力的心脏中具有轻微的亲纤维效应.
矛盾的是,LARP6的过度表达可以防止血管新素II诱导的心脏纤维化和功能障碍.
持续诱导LARP6证明了对高血压心脏病的治疗潜力.

关键词:

这种核糖核蛋白6 心脏过度缩小的心脏过度缩小超声心电图 (Echocardiography) 是一种心声回声仪.纤维化纤维化这种高血压,高血压.

更多相关视频

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...